查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1478677

乳癌治療市場、佔有率、規模、趨勢、行業分析報告：依治療、依癌症類型、依分銷管道、依地區、細分市場預測，2024-2032 年

Breast Cancer Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Chemotherapy, Hormonal Therapy, Targeted Therapy); By Cancer Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球乳癌治療市場規模預計將達到 631.3 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

推動乳癌治療市場向前發展的因素包括乳癌發生率上升、技術進步、個人化醫療需求不斷增加、政府措施以及醫療支出不斷增加。此外，不斷增長的治療藥物正在推動市場競爭並吸引投資。隨著研究的進展，新藥和替代療法的出現預計將推動市場的進一步成長。例如，2023 年 4 月，英國將為數千名乳癌患者提供一種針對遺傳性基因突變的開創性癌症治療方法。

免疫療法，特別是檢查點抑制劑，已顯示出透過激活免疫系統識別和對抗癌細胞來治療某些類型乳癌的前景。例如，帕博利珠單抗和納武單抗等 PD-1 抑制劑正在進行針對三陰性乳癌 (TNBC) 的臨床試驗。人們也正在努力將免疫療法與化療和標靶療法等其他治療方法結合，以改善乳癌患者的預後。

隨著醫療基礎設施的改善，亞洲、非洲和拉丁美洲新興市場對乳癌的認識不斷提高。這些努力包括加強乳癌早期檢測、診斷和治療的措施。這些地區的可支配收入不斷增加，使更多人能夠獲得先進的治療，從而為乳癌治療市場的提供者創造了巨大的成長機會。

乳癌治療市場報告亮點

到2023 年，與標靶藥物的引入相關的重大變化，例如針對參與乳癌生長和生存的其他細胞途徑的新藥物，在臨床研究中顯示出前景，將促使標靶治療設計領域的轉變主導市場。

荷爾蒙受體細分市場將在 2023 年引領市場，並且由於乳癌發病率上升，預計將保持其主導地位。

北美在全球乳癌治療市場中佔有重要的銷售佔有率，因為該地區乳癌發生率較高，對有效治療方案產生了強烈需求。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球乳癌治療市場洞察

  • 分銷通路快照
  • 乳癌治療市場動態
    • 推動者和機會
      • 世界各地的乳癌發生率正在上升
      • 個人化醫療的進展
    • 抑制因素和課題
      • 市場擴張預計將因專利到期而受到阻礙
  • PESTEL 分析
  • 乳癌治療市場通路的趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第五章全球乳癌治療市場：依治療分類

  • 主要發現
  • 簡介
  • 化療
  • 荷爾蒙療法
  • 標靶治療
  • 免疫治療
  • 放射治療及手術治療

第 6 章全球乳癌治療市場：依癌症類型劃分

  • 主要發現
  • 簡介
  • 荷爾蒙受體
  • HER2 陽性
  • 其他

第七章全球乳癌治療市場：依通路劃分

  • 主要發現
  • 簡介
  • 零售藥局
  • 醫院藥房
  • 其他

第 8 章全球乳癌治療市場：地區

  • 主要發現
  • 簡介
    • 乳癌治療市場評估：依地區劃分，2019-2032 年
  • 北美
    • 北美：依療法分類，2019-2032 年
    • 北美：依通路劃分，2019-2032 年
    • 北美：以癌症類型劃分，2019-2032 年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依療法分類，2019-2032 年
    • 歐洲：依通路劃分，2019-2032 年
    • 歐洲：依癌症類型劃分，2019-2032 年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依療法分類，2019-2032 年
    • 亞太地區：依通路劃分，2019-2032 年
    • 亞太地區：依癌症類型劃分，2019-2032 年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東/非洲
    • 中東和非洲：依療法分類，2019-2032 年
    • 中東與非洲：依通路劃分，2019-2032 年
    • 中東和非洲：依癌症類型劃分，2019-2032 年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依療法分類，2019-2032 年
    • 拉丁美洲：依通路劃分，2019-2032 年
    • 拉丁美洲：依癌症類型劃分，2019-2032 年
    • 墨西哥
    • 巴西
    • 阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協定/揭露

第十章公司簡介

  • Novartis AG
  • Pfizer Inc.
  • Merck KGaA
  • Janssen Pharmaceuticals, Inc
  • Celgene Corporation, Inc
  • Genzyme Corp
  • F. Hoffmann-La Roche Ltd
  • AstraZeneca
  • AbbVie Inc
  • Bristol-Myers Squibb Company
  • Macrogenics, Inc
  • Celldex Therapeutics
  • Onyx Pharmaceuticals Inc.
Product Code: PM1534

The global Breast Cancer Therapy market size is expected to reach USD 63.13 billion by 2032, according to a new study by Polaris Market Research. The report "Breast Cancer Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Chemotherapy, Hormonal Therapy, Targeted Therapy); By Cancer Type; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The factors propelling the breast cancer therapy market forward, are the rising occurrence of breast cancer, technological advancements, heightened demand for personalized medicine, government initiatives, and augmented healthcare spending. Additionally, the expanding drug pipeline for treatment is fostering competition and attracting investment in the market. As research progresses, we can expect the emergence of new drugs and treatment alternatives to drive further market growth. For instance, in April 2023, England plans to offer thousands of breast cancer patients a pioneering oncology drug designed to target a hereditary genetic mutation.

Immunotherapy, especially checkpoint inhibitors, has demonstrated potential in treating specific types of breast cancer by activating the immune system to identify and combat cancer cells. For instance, PD-1 inhibitors like pembrolizumab and nivolumab are undergoing clinical trials for triple-negative breast cancer (TNBC), which is typically more aggressive and challenging to treat with conventional methods. There is also ongoing exploration of combining immunotherapy with other treatments, such as chemotherapy or targeted therapy, to enhance outcomes for breast cancer patients.

In emerging markets across Asia, Africa, and Latin America, there is a rising awareness of breast cancer alongside efforts to improve healthcare infrastructure. These efforts include initiatives to bolster early detection, diagnosis, and treatment of breast cancer. With increasing disposable incomes in these regions, more individuals can access and afford advanced treatments, thereby presenting substantial growth opportunities for providers of the breast cancer therapy market.

Breast Cancer Therapy Market Report Highlights

The targeted therapy design segment dominated the market in 2023, driven by significant transformation with the introduction of targeted medicines, such as novel medications that target other cellular pathways involved in the growth and survival of breast cancer are also showing promise in clinical studies.

The hormone receptor segment led the market in 2023 and is expected to maintain its dominance due to the rising incidence of breast cancer.

North America holds a significant revenue share in the global breast cancer therapy market, driven by the region experiences high incidence of breast cancer, creating a strong demand for effective treatment options.

The global key market players include Novartis AG, Pfizer Inc., Merck KGaA, Janssen Pharmaceuticals, Inc., Celgene Corporation, Inc., Genzyme Corp., F. Hoffmann-La Roche Ltd., AstraZeneca, AbbVie Inc., Bristol-Myers Squibb Company and Macrogenics, Inc.

Polaris Market Research has segmented the Breast Cancer Therapy market report based on therapy, cancer type, distribution channel, and region:

Breast Cancer Therapy, Therapy Outlook (Revenue - USD Billion, 2019 - 2032)

  • Chemotherapy
  • Hormonal Therapy
  • Aromatase Inhibitors
  • Estrogen Receptor Down regulators (ERDs)
  • Selective Estrogen Receptor Modulators (SERMs)
  • Targeted Therapy
  • Ribociclib
  • Palbociclib
  • Pertuzumab
  • Olaparib
  • Abemaciclib
  • Ado-Trastuzumab Emtansine
  • Everolimus
  • Trastuzumab
  • Others
  • Immunotherapy
  • Radiation & Surgery Therapy

Breast Cancer Therapy, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hormone Receptor
  • HER2+
  • Others

Breast Cancer Therapy, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

Breast Cancer Therapy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Breast Cancer Therapy Market Insights

  • 4.1. Breast Cancer Therapy Market - Distribution Channel Snapshot
  • 4.2. Breast Cancer Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Worldwide Breast Cancer Incidence Rate
      • 4.2.1.2. Advancements in Personalized Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Patent expiry is expected to hinder market expansion
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Breast Cancer Therapy Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Breast Cancer Therapy Market, by Therapy

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • 5.3. Chemotherapy
    • 5.3.1. Global Breast Cancer Therapy Market, by Chemotherapy, by Region, 2019-2032 (USD Billion)
  • 5.4. Hormonal Therapy
    • 5.4.1. Global Breast Cancer Therapy Market, by Hormonal Therapy, by Region, 2019-2032 (USD Billion)
    • 5.4.2. Aromatase Inhibitors
      • 5.4.2.1. Global Breast Cancer Therapy Market, by Aromatase Inhibitors, by Region, 2019-2032 (USD Billion)
    • 5.4.3. Estrogen Receptor Down regulators (ERDs)
      • 5.4.3.1. Global Breast Cancer Therapy Market, by Estrogen Receptor Down regulators (ERDs), by Region, 2019-2032 (USD Billion)
    • 5.4.4. Selective Estrogen Receptor Modulators (SERMs)
      • 5.4.4.1. Global Breast Cancer Therapy Market, by Selective Estrogen Receptor Modulators (SERMs), by Region, 2019-2032 (USD Billion)
  • 5.5. Targeted Therapy
    • 5.5.1. Global Breast Cancer Therapy Market, by Targeted Therapy, by Region, 2019-2032 (USD Billion)
    • 5.5.2. Ribociclib
      • 5.5.2.1. Global Breast Cancer Therapy Market, by Ribociclib, by Region, 2019-2032 (USD Billion)
    • 5.5.3. Palbociclib
      • 5.5.3.1. Global Breast Cancer Therapy Market, by Palbociclib, by Region, 2019-2032 (USD Billion)
    • 5.5.4. Pertuzumab
      • 5.5.4.1. Global Breast Cancer Therapy Market, by Pertuzumab, by Region, 2019-2032 (USD Billion)
    • 5.5.5. Olaparib
      • 5.5.5.1. Global Breast Cancer Therapy Market, by Olaparib, by Region, 2019-2032 (USD Billion)
    • 5.5.6. Abemaciclib
      • 5.5.6.1. Global Breast Cancer Therapy Market, by Abemaciclib, by Region, 2019-2032 (USD Billion)
    • 5.5.7. Ado-Trastuzumab Emtansine
      • 5.5.7.1. Global Breast Cancer Therapy Market, by Ado-Trastuzumab Emtansine, by Region, 2019-2032 (USD Billion)
    • 5.5.8. Everolimus
      • 5.5.8.1. Global Breast Cancer Therapy Market, by Everolimus, by Region, 2019-2032 (USD Billion)
    • 5.5.9. Trastuzumab
      • 5.5.9.1. Global Breast Cancer Therapy Market, by Trastuzumab, by Region, 2019-2032 (USD Billion)
    • 5.5.10. Others
      • 5.5.10.1. Global Breast Cancer Therapy Market, by Others, by Region, 2019-2032 (USD Billion)
  • 5.6. Immunotherapy
    • 5.6.1. Global Breast Cancer Therapy Market, by Immunotherapy, by Region, 2019-2032 (USD Billion)
  • 5.7. Radiation & Surgery Therapy
    • 5.7.1. Global Breast Cancer Therapy Market, by Radiation & Surgery Therapy, by Region, 2019-2032 (USD Billion)

6. Global Breast Cancer Therapy Market, by Cancer Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • 6.3. Hormone Receptor
    • 6.3.1. Global Breast Cancer Therapy Market, by Hormone Receptor, by Region, 2019-2032 (USD Billion)
  • 6.4. HER2+
    • 6.4.1. Global Breast Cancer Therapy Market, by HER2+, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Breast Cancer Therapy Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Breast Cancer Therapy Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Retail Pharmacies
    • 7.3.1. Global Breast Cancer Therapy Market, by Retail Pharmacies, By Region, 2019-2032 (USD Billion)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Global Breast Cancer Therapy Market, by Hospital Pharmacies, By Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Breast Cancer Therapy Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Breast Cancer Therapy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Breast Cancer Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Breast Cancer Therapy Market - North America
    • 8.3.1. North America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
    • 8.3.2. North America: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.3.4. Breast Cancer Therapy Market - U.S.
      • 8.3.4.1. U.S.: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.3.5. Breast Cancer Therapy Market - Canada
      • 8.3.5.1. Canada: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • 8.4. Breast Cancer Therapy Market - Europe
    • 8.4.1. Europe: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.4. Breast Cancer Therapy Market - UK
      • 8.4.4.1. UK: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.5. Breast Cancer Therapy Market - France
      • 8.4.5.1. France: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.6. Breast Cancer Therapy Market - Germany
      • 8.4.6.1. Germany: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.7. Breast Cancer Therapy Market - Italy
      • 8.4.7.1. Italy: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.8. Breast Cancer Therapy Market - Spain
      • 8.4.8.1. Spain: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.9. Breast Cancer Therapy Market - Netherlands
      • 8.4.9.1. Netherlands: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.10. Breast Cancer Therapy Market - Russia
      • 8.4.10.1. Russia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • 8.5. Breast Cancer Therapy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.4. Breast Cancer Therapy Market - China
      • 8.5.4.1. China: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.5. Breast Cancer Therapy Market - India
      • 8.5.5.1. India: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.6. Breast Cancer Therapy Market - Malaysia
      • 8.5.6.1. Malaysia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.7. Breast Cancer Therapy Market - Japan
      • 8.5.7.1. Japan: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.8. Breast Cancer Therapy Market - Indonesia
      • 8.5.8.1. Indonesia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.9. Breast Cancer Therapy Market - South Korea
      • 8.5.9.1. South Korea: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • 8.6. Breast Cancer Therapy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.4. Breast Cancer Therapy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.5. Breast Cancer Therapy Market - UAE
      • 8.6.5.1. UAE: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.6. Breast Cancer Therapy Market - Israel
      • 8.6.6.1. Israel: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.7. Breast Cancer Therapy Market - South Africa
      • 8.6.7.1. South Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • 8.7. Breast Cancer Therapy Market - Latin America
    • 8.7.1. Latin America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.7.4. Breast Cancer Therapy Market - Mexico
      • 8.7.4.1. Mexico: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.7.5. Breast Cancer Therapy Market - Brazil
      • 8.7.5.1. Brazil: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.7.6. Breast Cancer Therapy Market - Argentina
      • 8.7.6.1. Argentina: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Novartis AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Pfizer Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Merck KGaA
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Janssen Pharmaceuticals, Inc
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Celgene Corporation, Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Genzyme Corp
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. F. Hoffmann-La Roche Ltd
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. AstraZeneca
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. AbbVie Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Bristol-Myers Squibb Company
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Macrogenics, Inc
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Celldex Therapeutics
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Onyx Pharmaceuticals Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development

List of Tables

  • Table 1 Global Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 2 Global Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 3 Global Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Breast Cancer Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 6 North America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 7 North America: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 9 U.S.: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 12 Canada: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 15 Europe: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 18 UK: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 19 UK: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 21 France: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 22 France: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 24 Germany: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 27 Italy: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 30 Spain: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 36 Russia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 42 China: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 43 China: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 45 India: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 46 India: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 51 Japan: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 57 South Korea: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 66 UAE: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 69 Israel: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 72 South Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 75 Latin America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 78 Mexico: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 81 Brazil: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 84 Argentina: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Breast Cancer Therapy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Cancer Type
  • Figure 7. Global Breast Cancer Therapy Market, by Cancer Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Therapy
  • Figure 9. Global Breast Cancer Therapy Market, by Therapy, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Breast Cancer Therapy Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Breast Cancer Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Breast Cancer Therapy Market